| Article Dump |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Health and Fitness > Diseases > Dementia Medications |
|
Article Dump - Dementia Medications
As is well known there is nothing that can be done to halt the underlying pathological processes involved in dementia. However, som According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ething can be done to alleviate the associated symptoms and to prevent distress in dementia sufferers. This article describes some ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in of the medications which are being currently used to treat the symptoms, and what they do. Sleep disturbance, agitation and depress lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ion are common symptoms associated with dementia, and they can be managed by the use of suitable (usually prescription-only) drugs. here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe Nocturnal restlessness is particularly wearing on the family or the carers, and the use of hypnotics (chloral, chlormethiazole, a s d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro hort-acting benzodiazepine such as temazepam or lorazepam, or a combination of small doses of a chloral compound with a tranquillizi ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc ng drug such as promazine) can be of some help. However, improved sleep may be associated with increased incontinence of urine and easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi hose caring for the dementia sufferer may need to make sure they use disposable absorbent pads at night. Barbiturates will be avoid nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ed for night sedation, or the control of agitation, because they tend to produce confusion. Phenothiazines, such as thioridazine an and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ d promazine, or haloperidol, are helpful in relieving agitation and aggressive or repetitive behavior, but care must be taken with s ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi uch drugs which all have unwanted side effects. Buspirone is often initially tried for mild-to-moderate anxiety. When depression i ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a s marked it will be treated with tetracyclic antidepressants in order to avoid the toxic effects on the heart of the tricyclic group dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod . Some drugs such as Memantine have been approved for treatment of moderate to severe Alzheimer’s disease. Using this kind of NMDA cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin (N-methyl-D-aspartate) blocker can lead to modest improvement in activities of daily living which are so important to sufferers and tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen to carers, such as eating, grooming and dressing. Even small improvements can make a significant difference to carers in their inte t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel ractions with the person with dementia. Other studies have reported similar improvements through the use of selegiline. Other medi ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust cations used in dementia include estrogens (in women); antioxidants, particularly in vascular dementia; and anti-inflammatory agents y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products , presumably because they may protect blood flow in the brain. Finally, statins (such as atorvastatin or pravastatin) may reduce th . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de e chance of developing Alzheimer's disease in the first place. Choline and lecithin have been used in the treatment of Alzheimer's elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip disease on the assumption that there is failure of acetylcholine synthesis, but there is no firm evidence yet of any practical value tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Checklist for Starting a Business Unsecured Loans – An Instant Financial Solution The Problem with Cognitive Therapy
|